---
annotations:
- type: Pathway Ontology
  value: signaling pathway
authors:
- ReactomeTeam
- Anwesha
- Ryanmiller
description: The first known downstream component of TLR4 and TLR2 signaling is the
  adaptor MyD88. Another adapter MyD88-adaptor-like (Mal; also known as TIR-domain-containing
  adaptor protein or TIRAP) has also been described for TLR4 and TLR2 signaling. MyD88
  comprises an N-terminal Death Domain (DD) and a C-terminal TIR, whereas Mal lacks
  the DD. The TIR homotypic interactions bring adapters into contact with the activated
  TLRs, whereas the DD modules recruit serine/threonine kinases such as interleukin-1-receptor-associated
  kinase (IRAK). Recruitment of these protein kinases is accompanied by phosphorylation,
  which in turn results in the interaction of IRAKs with TNF-receptor-associated factor
  6 (TRAF6). The oligomerization of TRAF6 activates TAK1, a member of the MAP3-kinase
  family, and this leads to the activation of the IkB kinases. These kinases, in turn,
  phosphorylate IkB, leading to its proteolytic degradation and the translocation
  of NF-kB to the nucleus. Concomitantly, members of the activator protein-1 (AP-1)
  transcription factor family, Jun and Fos, are activated, and both AP-1 transcription
  factors and NF-kB are required for cytokine production, which in turn produces downstream
  inflammatory effects.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=166058
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP2761
- /instance/WP2761
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP2761.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The first known downstream component of TLR4 and TLR2 signaling is
    the adaptor MyD88. Another adapter MyD88-adaptor-like (Mal; also known as TIR-domain-containing
    adaptor protein or TIRAP) has also been described for TLR4 and TLR2 signaling.
    MyD88 comprises an N-terminal Death Domain (DD) and a C-terminal TIR, whereas
    Mal lacks the DD. The TIR homotypic interactions bring adapters into contact with
    the activated TLRs, whereas the DD modules recruit serine/threonine kinases such
    as interleukin-1-receptor-associated kinase (IRAK). Recruitment of these protein
    kinases is accompanied by phosphorylation, which in turn results in the interaction
    of IRAKs with TNF-receptor-associated factor 6 (TRAF6). The oligomerization of
    TRAF6 activates TAK1, a member of the MAP3-kinase family, and this leads to the
    activation of the IkB kinases. These kinases, in turn, phosphorylate IkB, leading
    to its proteolytic degradation and the translocation of NF-kB to the nucleus.
    Concomitantly, members of the activator protein-1 (AP-1) transcription factor
    family, Jun and Fos, are activated, and both AP-1 transcription factors and NF-kB
    are required for cytokine production, which in turn produces downstream inflammatory
    effects.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=166058
    Reactome].
  keywords:
  - 'TLR1 '
  - UBE2N:UBE2V1
  - TRAF6:K63-linked
  - 'UBE2V1 '
  - 'p-PELI2 '
  - 'Lipoteichoic acid '
  - p-S,2T-IRAK4:oligo-MyD88:TIRAP:activated TLR receptor
  - p-IRAK2:p-IRAK4:oligo-MyD88:TIRAP:activated TLR
  - CHUK:IKBKB:IKBKG
  - IRAK2:p-S,2T-IRAK4:oligo-MyD88:Mal:activated TLR
  - IKKs complex
  - 'p-T184,T187-MAP3K7 '
  - 'TLR2 '
  - 'PI(4,5)P2 '
  - TRAF6:hp-IRAK1:p-IRAK4:oligo-MyD88:TIRAP:activated TLR
  - 'K63polyUb-hp-IRAK1 '
  - Ub
  - 'p-T209-IRAK1 '
  - 'p-T209,T387-IRAK1 '
  - 'mip '
  - 'UBE2N '
  - 'p-PELI1 '
  - MAP kinase
  - 'UBB(77-152) '
  - 'Major outer membrane protein P '
  - IRAK4
  - p-Pellino:hp-IRAK1:TRAF6
  - activation
  - 'MAP3K7 '
  - complex
  - 'p-4Y-TIRAP '
  - 'IRAK4 '
  - oligo-MyD88:TIRAP:BTK:activated TLR
  - K63-linked polyUb
  - pUb
  - 'UBC(77-152) '
  - 'TRAF6 '
  - 'IKBKG '
  - p-IRAK1:TRAF6
  - Activated TLR1:2 or
  - ECSIT
  - '2xN4GlycoAsn-LY96 '
  - IRAK3
  - 'CHUK '
  - p-Pellino-1,2,(3)
  - SOCS1
  - ATP
  - pUb:p-TAK1complex
  - 'BTK '
  - 'TAB3 '
  - TRAF6:hp-IRAK1
  - polyUb p-IRAK1:IKK
  - 'p-T342,T345,S346-IRAK4 '
  - SIGIRR
  - :p-IRAK4:oligo-MyD88:TIRAP:activated TLR
  - 'UBB(1-76) '
  - 'K63polyUb '
  - K63 pUb:TAK1
  - 'UBC(153-228) '
  - TAK1 complex
  - 'UBB(153-228) '
  - p-IRAK2:K63-linked
  - TLR2/4:p-4Y-TIRAP:PI(4,5)P2:BTK
  - MyD88:TIRAP:BTK:activated TLR2/4
  - TRAF6:hp-IRAK1:Pellino
  - IRAK4:oligo-MyD88:TIRAP:activated TLR
  - 'K63polyUb-TRAF6 '
  - MAP3K1
  - TIRAP
  - 'TAB1 '
  - IRAK1:p-S,2T-IRAK4
  - 'IKBKB '
  - MYD88
  - 'UBC(533-608) '
  - IRAK1, IRAK2
  - TLR 2:6
  - 'UBA52(1-76) '
  - TAK1 activates NFkB
  - 'TLR6 '
  - BTK
  - ADP
  - :oligo-MyD88:TIRAP:activated TLR
  - 'UBC(457-532) '
  - oligo-TRAF6:free
  - IRAK2:p-IRAK4:MyD88
  - 'Triacyl lipopeptide '
  - 'GPIN-CD14(20-345) '
  - IRAK1/or
  - 'LPS '
  - 'MAP3K1 '
  - TRAF6:p-IRAK2
  - p-IRAK1:p-IRAK4:oligo-MyD88:TIRAP:activated TLR
  - activated
  - pUb oligo-TRAF6
  - heterodimers or
  - TIRAP:PI(4,5)P2
  - '4xPalmC-CD36 '
  - TRAF6
  - 'Clostridial peptidoglycan '
  - 'RPS27A(1-76) '
  - p-3S,3T-IRAK1:p-S,2T-IRAK4:oligo-MyD88:TIRAP:activated TLR
  - 'UBC(305-380) '
  - TLR4 homodimer
  - 'TIRAP '
  - 'p-2S,S376,T,T209,T387-IRAK1 '
  - 'Diacyl lipopeptide '
  - 'IRAK1 '
  - oligomer:TIRAP:activated TLR
  - by phosphorylation
  - MEKK1:activated
  - p-IRAK2:oligo-TRAF6
  - 'UBC(609-684) '
  - '2xN4GlycoAsn-TLR4 '
  - K63polyUb
  - TIRAP:PI(4,5)P2:BTK:activated TLR2/4
  - TIRAP:PI(4,5)P2:activated TLR2/4
  - K63-linked
  - 'IRAK2 '
  - 'UBC(381-456) '
  - and activation of
  - PI(4,5)P2
  - 'TAB2 '
  - 'UBC(229-304) '
  - 'p-IRAK2 '
  - 'MYD88 '
  - 'UBC(1-76) '
  - pp-IRAK1:p-IRAK4:oligo-MyD88:TIRAP:activated TLR
  - 'CD14(20-345) '
  - 'p-PELI3 '
  license: CC0
  name: MyD88:MAL(TIRAP) cascade initiated on plasma membrane
seo: CreativeWork
title: MyD88:MAL(TIRAP) cascade initiated on plasma membrane
wpid: WP2761
---